Two Sigma Advisers
TNXP icon

Two Sigma Advisers’s Tonix Pharmaceuticals TNXP Stock Holding History

Two Sigma Advisers’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$182K – 2874
2022
Q1 		$182K Hold
1
– – ﹤0.01% 2405
2021
Q4 		$307K Buy
+1
New +$318K ﹤0.01% 2134
2021
Q3 		– Hold
0
– – – 2388

Other funds holding TNXP

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's TNXP Position: Q2 2022 in Review

Two Sigma Advisers sold out of Tonix Pharmaceuticals (TNXP) in Q2 2022, closing a stake of 1 share — an estimated $182K sold.

Two Sigma Advisers first reported a position in TNXP in Q4 2021 and held it in 2 quarters. The position peaked at $307K in Q4 2021. 23 funds tracked by Wall St. Rank hold TNXP as of Q2 2022.

  • Two Sigma Advisers reported no remaining Tonix Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 1 Tonix Pharmaceuticals share in Q2 2022, an estimated $182K.
  • Two Sigma Advisers first reported a position in Tonix Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Tonix Pharmaceuticals position peaked at $307K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.